Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;21(2):e297-e301.
doi: 10.18295/squmj.2021.21.02.020. Epub 2021 Jun 21.

Analysis of Bone Microarchitectural Changes and Structural Damage in Sickle Cell Disease-Induced Avascular Necrosis Using Raman Spectroscopy: Is there potential for medical management?

Affiliations

Analysis of Bone Microarchitectural Changes and Structural Damage in Sickle Cell Disease-Induced Avascular Necrosis Using Raman Spectroscopy: Is there potential for medical management?

Ahmed Al-Ghaithi et al. Sultan Qaboos Univ Med J. 2021 May.

Abstract

Objectives: Bone failure due to avascular necrosis (AVN) is a complex pathological phenomenon. Analysis of molecular changes in the bone matrix may help to shed light on the disease process and guide management. This study aimed to explore changes in bone quality and structural damage caused by sickle cell disease (SCD)-induced AVN using Raman spectroscopy.

Methods: A total of 10 necrotic femoral heads were obtained from seven SCD patients who underwent total hip replacements. The femoral heads were cut in half and scanned using Raman spectroscopy in correlation with preoperative magnetic resonance imaging to identify necrotic and healthy control areas. Subsequently, samples were examined to determine changes in bone mineralisation, crystallinity, carbonate content, collagen cross-linking and mineral and collagen fibril orientation.

Results: Significant changes were observed in bone mineral content, mineral-to-organic content and collagen fibril orientation in necrotic compared to control areas (P ≤0.050).

Conclusion: The necrotic samples displayed severe structural damage and loss of mineral and organic contents. Similar Raman signals have been reported in other metabolic bone diseases such as osteoporosis, thereby potentially supporting the use of medical treatment in AVN to promote bone quality.

Keywords: Bone Density; Bone Mineralization; Bone Remodeling; Extracellular Matrix; Femur Head Necrosis; Osteonecrosis; Raman Spectroscopy; Sickle Cell Disease.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
A: Photograph of the bisected femoral head of a patient with sickle cell disease-induced avascular necrosis showing necrosis in the subchondral area (arrow). B: Preoperative magnetic resonance imaging showing the same necrotic area as a hypointense signal (arrowhead).
Figure 2
Figure 2
Graphs comparing the acquired Raman spectra of (A) normal bone and (B) bone collected from femoral heads affected by sickle cell disease-induced avascular necrosis (N = 10). The normal bone shows peaks at 958 cm−1 for phosphate, 1,070 cm−1 for carbonate, 1,660 cm−1 for amide I and 1,684 cm−1 for amide II. It demonstrates the overall drop in spectra of necrotised bone.
Figure 3
Figure 3
Charts showing the average acquired Raman spectra from bone samples collected from femoral heads affected by sickle cell disease-induced avascular necrosis (N = 10). In comparison to healthy control areas, the necrotic areas showed (A) an increased carbonate-to-phosphate ratio, indicating a difference in bone crystallinity and transformation to a brittle matrix, (B & C) reduced phosphate-to-amide and carbonate-to-amide ratios, indicating a reduction in mineral relative to organic material, and (D) a reduced collagen crosslinking ratio, indicating increased collagen cross-linkage disruption. AVN = avascular necrosis.

Similar articles

Cited by

References

    1. Clarke B. Normal bone anatomy and physiology. Clin J Am Soc Nephrol. 2008;3:S131–9. doi: 10.2215/CJN.04151206. - DOI - PMC - PubMed
    1. Boettcher WG, Bonfiglio M, Hamilton HH, Sheets RF, Smith K. Non-traumatic necrosis of the femoral head: I. Relation of altered hemostasis to etiology. J Bone Joint Surg Am. 1970;52:312–21. doi: 10.2106/00004623-197052020-00012. - DOI - PubMed
    1. Vaishya R, Agarwal AK, Edomwonyi EO, Vijay V. Musculo-skeletal manifestations of sickle cell disease: A review. Cureus. 2015;7:e358. doi: 10.7759/cureus.358. - DOI - PMC - PubMed
    1. Marker DR, Seyler TM, McGrath MS, Delanois RE, Ulrich SD, Mont MA. Treatment of early stage osteonecrosis of the femoral head. J Bone Joint Surg Am. 2008;90:175–87. doi: 10.2106/JBJS.H.00671. - DOI - PubMed
    1. Agarwala S, Jain D, Joshi VR, Sule A. Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip: A prospective open-label study. Rheumatology (Oxford) 2005;44:352–9. doi: 10.1093/rheumatology/keh481. - DOI - PubMed

LinkOut - more resources